The impact of COVID-19 pandemic on colorectal cancer therapy

The impact of COVID-19 pandemic on colorectal cancer therapy - The impact of COVID-19 pandemic on colorectal cancer therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042211

Enrollment

123

Registered

2020-10-23

Start date

2020-08-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients are eligible for this study if they meet the following criteria. Colorectal cancer patients who underwent surgery at participating institution Those who do not refuse to participate in this study

Exclusion criteria

Exclusion criteria: Patients deemed ineligible as study participants by the research director

Design outcomes

Primary

Measure	Time frame
The incidence of obstructive colorectal cancer	—

Secondary

Measure	Time frame
Patients' characteristics (Age, Sex, Emergency Admission, preoperative hemoglobin, preoperative CEA, Tumor location, pathological findings, residence, Events contributing to the detection of colorectal cancer), Numbers of surgery, colonoscopy and outpatients	—

Countries

Japan

Contacts

Public ContactMizuno Rei

Uji-Tokushukai Medical Center Department of Surgery

reimzn@kuhp.kyoto-u.ac.jp0774201111

Outcome results